Morgan Stanley Athersys, Inc Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	BUY	$0.18 - $0.86 $18,955 - $90,565	105,309 Added 28.98%	468,725 $121,000
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.86 $18,955 - $90,565	105,309 Added 28.98%	468,725 $121,000
Q1 2022 Oct 27, 2022	SELL	$0.6 - $1.06 $63,185 - $111,627	-105,309 Reduced 22.47%	363,416 $220,000
Q1 2022 May 13, 2022	BUY	$0.6 - $1.06 $29,697 - $52,464	49,495 Added 15.77%	363,416 $220,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $715 - $1,178	842 Added 0.27%	313,921 $283,000
Q3 2021 Nov 15, 2021	BUY	$1.33 - $1.77 $416,395 - $554,149	313,079 New	313,079 $416,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.